Source: Milwaukee Journal Sentinel
Posted: August 1, 2007
Summary:
The Milwaukee Journal Sentinel reports on a new study that could hasten treatments for Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig's disease:
"A University of Wisconsin-Madison study could be an important development in finding new treatments for Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig's disease. The study, published in the journal Public Library of Science (PloS) One, found that genetically engineered fetal stem cells implanted in rats with ALS provided substantial protection for motor neurons, the nerve cells that die in ALS."
